{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:46:48Z","timestamp":1786970808582,"version":"build-2736575974"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p><jats:italic>Toxoplasma gondii<\/jats:italic>is an apicomplexan pathogen infecting 2 billion people and numerous livestock, causing a major threat to economies and human health. Passive-active immunoprophylaxis is an efficient approach to provide protection against toxoplasmosis.<jats:italic>T. gondii<\/jats:italic>perforin-like protein 2 (TgPLP2) contains a membrane attack complex\/perforin (MACPF) domain, making it a potential vaccine candidate. Here, we aimed to assess the protection efficacy of TgPLP2 using Bagg albino\/c (BALB\/c) mice model. The<jats:italic>Escherichia coli<\/jats:italic>system was used to obtain the recombinant TgPLP2 (rTgPLP2). Mice challenged by anti-rTgPLP2 polyclonal antibodies (PcAb) pretreated tachyzoites showed obviously increased survival outcomes. In addition, mice that passively received anti-rTgPLP2 PcAb following a lethal dose of tachyzoites infection had longer survival time compared with phosphate-buffered saline (PBS) controls. Furthermore, we demonstrated that immunization with rTgPLP2 could prolong survival in RH strain infected mice and resulted in the lowest brain cysts size and number of Prugniaud (PRU) genotype II strain infected mice. High levels of<jats:italic>Toxoplasma<\/jats:italic>-specific IgG, IgG1, IgG2a, and cytokines (IFN-\u03b3 and IL-10) were produced after two immunizations with rTgPLP2. Together these results indicated that TgPLP2 can induce both humoral and cellular immune responses to protect host against infection and thus is a potential candidate for<jats:italic>T. gondii<\/jats:italic>vaccines.<\/jats:p>","DOI":"10.3389\/fvets.2021.802250","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T16:54:45Z","timestamp":1645030485000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["A Novel Vaccine Candidate: Recombinant Toxoplasma gondii Perforin-Like Protein 2 Stimulates Partial Protective Immunity Against Toxoplasmosis"],"prefix":"10.3389","volume":"8","author":[{"given":"Xiaowei","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanqi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangmin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefang","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangrui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,15]]},"reference":[{"key":"B1","article-title":"Toxoplasmosis","volume-title":"StatPearls","author":"Madireddy","year":"2021"},{"key":"B2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.rvsc.2020.10.019","article-title":"Foodborne transmission of Toxoplasma gondii infection in the last decade. An overview","volume":"135","author":"Almeria","year":"2021","journal-title":"Res Vet Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1645\/GE-3189.1","article-title":"Toxoplasma gondii presence in women with spontaneous abortion in Yucatan, Mexico","volume":"99","author":"Vado-Sol\u00eds","year":"2013","journal-title":"J Parasitol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.vetpar.2012.09.037","article-title":"Toxoplasma gondii abortion storm in sheep on a Texas farm and isolation of mouse virulent atypical genotype T. gondii from an aborted lamb from a chronically infected ewe","volume":"192","author":"Edwards","year":"2013","journal-title":"Vet Parasitol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.meegid.2012.01.013","article-title":"Brain cancer mortality rates increase with Toxoplasma gondii seroprevalence in France","volume":"12","author":"Vittecoq","year":"2012","journal-title":"Infect Genet Evol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.biopha.2016.05.041","article-title":"Human toxoplasmosis-searching for novel chemotherapeutics","volume":"82","author":"Antczak","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1586\/14760584.2015.1098539","article-title":"Recent advances in developing vaccines against Toxoplasma gondii: an update","volume":"14","author":"Zhang","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.7774\/cevr.2019.8.1.4","article-title":"Rhoptry antigens as Toxoplasma gondii vaccine target","volume":"8","author":"Foroutan","year":"2019","journal-title":"Clin Exp Vaccine Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.7774\/cevr.2018.7.2.93","article-title":"Recent progress in microneme-based vaccines development against Toxoplasma gondii","volume":"7","author":"Foroutan","year":"2018","journal-title":"Clin Exp Vaccine Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1128\/CVI.05578-11","article-title":"Vaccination with a DNA vaccine coding for perforin-like protein 1 and MIC6 induces significant protective immunity against Toxoplasma gondii","volume":"19","author":"Yan","year":"2012","journal-title":"Clin Vaccine Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.mib.2015.05.001","article-title":"The Apicomplexan CDC\/MACPF-like pore-forming proteins","volume":"26","author":"Wade","year":"2015","journal-title":"Curr Opin Microbiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4161\/cib.3.1.9794","article-title":"Apicomplexan perforin-like proteins","volume":"3","author":"Kafsack","year":"2010","journal-title":"Commun Integr Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.exppara.2011.02.005","article-title":"Toxoplasma gondii: protective immunity against experimental toxoplasmosis induced by a DNA vaccine encoding the perforin-like protein 1","volume":"128","author":"Yan","year":"2011","journal-title":"Exp Parasitol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"8357","DOI":"10.4049\/jimmunol.179.12.8357","article-title":"Death receptor ligation or exposure to perforin trigger rapid egress of the intracellular parasite Toxoplasma gondii","volume":"179","author":"Persson","year":"2007","journal-title":"J Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1126\/science.1165740","article-title":"Rapid membrane disruption by a perforin-like protein facilitates parasite exit from host cells","volume":"323","author":"Kafsack","year":"2009","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-1-4939-3389-1_10","article-title":"Towards a preventive strategy for toxoplasmosis: current trends, challenges, and future perspectives for vaccine development","volume":"1404","author":"Fereig","year":"2016","journal-title":"Methods Mol Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1017\/S003118200000144X","article-title":"A commercial vaccine for ovine toxoplasmosis","volume":"110","author":"Buxton","year":"1995","journal-title":"Parasitology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3389\/fmicb.2018.00909","article-title":"Immune protection of rhoptry protein 21 (ROP21) of Toxoplasma gondii as a DNA vaccine against toxoplasmosis","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Microbiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fmicb.2017.00168","article-title":"Toxoplasma gondii elongation factor 1-alpha (TgEF-1\u03b1) is a novel vaccine candidate antigen against toxoplasmosis","volume":"8","author":"Wang","year":"2017","journal-title":"Front Microbiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s13071-017-2353-8","article-title":"The N- and C-terminal carbohydrate recognition domains of Haemonchus contortus galectin bind to distinct receptors of goat PBMC and contribute differently to its immunomodulatory functions in host-parasite interactions","volume":"10","author":"Lu","year":"2017","journal-title":"Parasit Vectors"},{"key":"B21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.vetpar.2018.06.020","article-title":"The molecular characterization and protective efficacy of microneme 3 of Eimeria mitis in chickens","volume":"258","author":"Huang","year":"2018","journal-title":"Vet Parasitol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3390\/vaccines8020158","article-title":"Identification of Toxoplasma gondii Tyrosine Hydroxylase (TH) activity and molecular immunoprotection against toxoplasmosis","volume":"8","author":"Zhang","year":"2020","journal-title":"Vaccines"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1017\/S0031182014000481","article-title":"Veterinary vaccines against toxoplasmosis","volume":"141","author":"Hiszczy\u0144ska-Sawicka","year":"2014","journal-title":"Parasitology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/1756-3305-7-431","article-title":"DNA vaccination with a gene encoding toxoplasma gondii deoxyribose phosphate aldolase (TgDPA) induces partial protective immunity against lethal challenge in mice","volume":"7","author":"Hassan","year":"2014","journal-title":"Parasit Vectors"},{"key":"B25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/vaccines9050413","article-title":"Advances in Toxoplasma gondii vaccines: current strategies and challenges for vaccine development","volume":"9","author":"Chu","year":"2021","journal-title":"Vaccines"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0020-7519(01)00261-2","article-title":"Surface antigens of Toxoplasma gondii: variations on a theme","volume":"31","author":"Lekutis","year":"2001","journal-title":"Int J Parasitol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2471\/BLT.16.178061","article-title":"Therapeutic antibodies for infectious diseases","volume":"95","author":"Sparrow","year":"2017","journal-title":"Bull World Health Organ"},{"key":"B28","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3347\/kjp.2001.39.3.233","article-title":"Effects of specific monoclonal antibodies to dense granular proteins on the invasion of Toxoplasma gondii in vitro and in vivo","volume":"39","author":"Cha","year":"2001","journal-title":"Korean J Parasitol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.parint.2009.12.007","article-title":"Monoclonal antibodies against nucleoside triphosphate hydrolase-II can reduce the replication of Toxoplasma gondii","volume":"59","author":"Tan","year":"2010","journal-title":"Parasitol Int."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.3389\/fimmu.2018.01814","article-title":"A lactate fermentation mutant of toxoplasma stimulates protective immunity against acute and chronic toxoplasmosis","volume":"9","author":"Xia","year":"2018","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.4049\/jimmunol.1801525","article-title":"The IL-12- and IL-23-dependent NK cell response is essential for protective immunity against secondary Toxoplasma gondii infection","volume":"203","author":"Ivanova","year":"2019","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/schbul\/sbm008","article-title":"Effects of Toxoplasma gondii infection on the brain","volume":"33","author":"Carruthers","year":"2007","journal-title":"Schizophr Bull"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1128\/IAI.01722-14","article-title":"Complex immune cell interplay in the gamma interferon response during Toxoplasma gondii infection","volume":"82","author":"Sturge","year":"2014","journal-title":"Infect Immun"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.4049\/jimmunol.180.9.5771","article-title":"IL-10: the master regulator of immunity to infection","volume":"180","author":"Couper","year":"2008","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"crossref","first-page":"798","DOI":"10.4049\/jimmunol.157.2.798","article-title":"In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha","volume":"157","author":"Gazzinelli","year":"1996","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jneuroim.2005.04.018","article-title":"A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis","volume":"165","author":"Wilson","year":"2005","journal-title":"J Neuroimmunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jaut.2014.04.001","article-title":"The immune potential and immunopathology of cytokine-producing B cell subsets: a comprehensive review","volume":"55","author":"Bao","year":"2014","journal-title":"J Autoimmun"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2021.802250\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T04:10:03Z","timestamp":1674792603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2021.802250\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,15]]},"references-count":37,"alternative-id":["10.3389\/fvets.2021.802250"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2021.802250","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,15]]},"article-number":"802250"}}